Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results
Maurizio Martelli(Sapienza University of Rome), C Ionescu(University of Bern), Elsa Pennese(Ospedale Vito Fazzi), Peter Johnson(Cancer Research UK), David Hodgson(The University of Texas MD Anderson Cancer Center), Luca Arcaini(University of Pavia), Kate Cwynarski(Royal London Hospital), Elisa Lucchini(Ospedale Santa Maria della Misericordia di Udine), Luca Ceriani(St Thomas' Hospital), Iryna Kriachok(National Cancer Institute), Monica Balzarotti(IRCCS Humanitas Research Hospital), Mats Jerkeman(Skåne University Hospital), Andrea Janíková(Masaryk University), Claudia Cellini(Ospedale Santa Maria), Vittorio Ruggero Zilioli(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Alessandro Re(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Annibale Versari(Azienda Sanitaria Unità Locale di Reggio Emilia), Benedetta Puccini(Azienda Ospedaliero-Universitaria Careggi), Giovannino Ciccone(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Stéphane Chauvie(Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo), Carla Minoia(Istituto Tumori Bari), Sally F. Barrington(King's College London), N. George Mikhaeel(Guy's and St Thomas' NHS Foundation Trust), Sara Veronica Usai(Ospedale di Circolo di Busto Arsizio), Alexander Fosså(Oslo University Hospital), Luigi Petrucci(Sapienza University of Rome), Jan Walewski(The Maria Sklodowska-Curie National Research Institute of Oncology), Umberto Ricardi(Azienda Ospedaliero Universitaria San Giovanni Battista), Mary Gospodarowicz(University Health Network), Alice Di Rocco(Policlinico Umberto I), Jacopo Olivieri(Ospedale Santa Maria della Misericordia di Udine), Barbara Botto, Ur Metser(Princess Margaret Cancer Centre), Francesco Merli(Azienda Sanitaria Unità Locale di Reggio Emilia), Bogdan Małkowski(Memorial Hospital), Andrew Davies(University Hospital Southampton NHS Foundation Trust), Weili Zhao(Ruijin Hospital), Anna Dąbrowska‐Iwanicka(The Maria Sklodowska-Curie National Research Institute of Oncology), Alessandra Tucci(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Michele Spina(National Cancer Institute), Yana Stepanishyna(National Cancer Institute), Marek Trněný(Charles University), Luigi Rigacci(Azienda Ospedaliero-Universitaria Careggi), Armando Santoro(IRCCS Humanitas Research Hospital), Emanuele Zucca(Università della Svizzera italiana), Andrés J.M. Ferreri(Vita-Salute San Raffaele University), Umberto Vitolo(Candiolo Cancer Institute), F. Cavalli(European School of Oncology)
Cited by 30
Related Papers
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
|Journal of Clinical Oncology|2014|1.6k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells
|New England Journal of Medicine|2004|1.4k
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
|New England Journal of Medicine|2014|1.1k